SciSparc Ltd. (NASDAQ:SPRC) Short Interest Down 63.1% in November

SciSparc Ltd. (NASDAQ:SPRC) saw a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 96,000 shares, a drop of 63.1% from the November 15th total of 260,200 shares. Based on an average daily volume of 985,100 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.9% of the company’s shares are short sold.

SciSparc Trading Down 7.1 %

Shares of NASDAQ:SPRC opened at $0.25 on Thursday. The stock has a 50-day simple moving average of $0.23 and a 200-day simple moving average of $0.45. SciSparc has a 1 year low of $0.21 and a 1 year high of $7.22.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SciSparc stock. Renaissance Technologies LLC bought a new stake in SciSparc Ltd. (NASDAQ:SPRC) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned 5.59% of SciSparc at the end of the most recent quarter. 25.06% of the stock is owned by hedge funds and other institutional investors.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.